Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care (KTESCA)

December 5, 2025 updated by: Centre Hospitalier Departemental Vendee

Peripheral Catheter Pressure Ulcer Prevention in Pediatry : Use of Compresses Versus Standard Care"

Peripheral venous catheterisation is a multi-daily practice in a paediatric ward.

In our pediatrics department, nurses have observed for several years now the appearance of pressure sore-like skin lesions at the junction of the peripheral venous catheter with the extension tube. A ward habit has spontaneously developed of applying a compress under this junction. The objective is to minimize physical or emotional aggression as well as pain. Pain that is denied or not identified and not relieved is memorized by the child, which can have consequences on the perception of pain and the subsequent acceptance of care.

To date, through their reading and research, investigators have been able to find articles mentioning the risks of pressure ulcers in children related to medical devices. However, few elements are developed concerning catheter-related pressure ulcers, especially on this specific technique for preventing injuries at the catheter-extension tube junction. Investigators have not found any recommendations on this subject.

Thus, the aim of this study is to compare two peripheral venous catheter fixation devices, with compress and without compress, and to analyse the frequency of pressure ulcer occurrence and the intensity of this lesion.

Study Overview

Study Type

Interventional

Enrollment (Actual)

360

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • La Roche-sur-Yon, France, 85000
        • CHD Vendee

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 1 month to 18 years old, according to the criteria of the paediatrics department of the Departmental Hospital la Roche sur Yon .
  • Hospitalized in paediatrics ward or consultant in paediatric emergencies with a high probability of being hospitalized in paediatrics ward later.
  • With an indication for the insertion of a short peripheral venous catheter
  • Written agreement from the holder(s) of parental authority

Exclusion Criteria:

  • Children with dermatological affections prior to inclusion and at the puncture site (atopic dermatitis, skin infection, skin wound, chickenpox, epidermolysis bullosa)
  • Allergy to fixation devices
  • Known immune deficient child
  • Refusal of the patient or of the holders of parental authority to participate
  • Life-saving emergency care
  • Patient already included in the study
  • Patient without social security coverage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: peripheral venous catheter with compress
Insertion of a peripheral venous catheter with a compress inserted below the catheter-extension tube junction
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot. The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department. Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride. Under the catheter-extension tube junction will be inserted a sterile non-woven compress, cut sterilely (3.5x1.5 cm). The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm). This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).
Active Comparator: peripheral venous catheter without compress
Insertion of a peripheral venous catheter without any compress inserted below the catheter-extension tube junction.
Placement of a BD Insyte® type catheter of 20 to 24 Gauge calibre on a peripheral vein located in the crease of the elbow or top of the hand or scalp or top of the foot. The catheter is placed while respecting the detersion and disinfection of the skin with the appropriate products and according to the procedure in force in the department. Once the venous return has been checked, a 10 cm extension with a BECTON-DIC® 3-way valve will be connected, which is previously purged with 0.9% Sodium Chloride. No compresses will be inserted under the catheter-extension tube junction.The assembly will be held in place by a transparent sterile semi-permeable adhesive dressing such as Tegaderm® (5x7 cm). This area will be secured by placing a crepe bandage (crepe bandage 4 m x7 cm).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure Ulcer of Grade >=1 on the National Pressure Ulcer Advisory Panel (NPUAP) Scale
Time Frame: at catheter removal

Occurrence of a pressure ulcer of grade ≥1 according to the NPUAP scale at the catheter extension junction. A higher grade on this scale indicates a worse patient outcome.

The assessment will be performed in a blinded manner by a childcare assistant (CDA) from the department.

at catheter removal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pressure ulcer intensity as measured by the NPUAP scale
Time Frame: at catheter removal
The NPUAP pressure ulcer rating scale translated in French by the National French Agency for accreditation and assessment of Health (ANAES) will be used. This scale evaluates pressure ulcers according to 4 stages graduated from 1 to 4. Stage 1 being the least severe.
at catheter removal
dwell time of peripheral venous catheters between the 2 groups
Time Frame: at catheter removal
Will be calculated from the time of catheter placement to the time of catheter removal.
at catheter removal
Presence of a nosocomial infection related to the peripheral venous catheter.
Time Frame: at catheter removal +48hours
Will be defined as a peripheral venous catheter culture > 10^3 Colony Forming Unit/ml, if the peripheral venous catheter is referred in culture on suspicion of infection and in the absence of antibiotic treatment. In the presence of antibiotic treatment, it will be defined by the presence of pus and/or regression of infectious signs within 48 hours after removal of the peripheral venous catheter.
at catheter removal +48hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: stephanie Chaillot, CHD Vendee

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 22, 2020

Primary Completion (Actual)

June 3, 2024

Study Completion (Actual)

June 3, 2024

Study Registration Dates

First Submitted

August 31, 2020

First Submitted That Met QC Criteria

September 4, 2020

First Posted (Actual)

September 7, 2020

Study Record Updates

Last Update Posted (Estimated)

December 23, 2025

Last Update Submitted That Met QC Criteria

December 5, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pressure Ulcer

Clinical Trials on peripheral venous catheter with compress under the catheter-extension tube junction

Subscribe